Platelet-Derived Growth Factor as a Therapeutic Target for Systemic Autoimmune Diseases

Some systemic rheumatic diseases and disorders, especially fibrotic and vascular disorders, are often refractory to corticosteroid therapy. Recently, ever accumulating evidence suggests that platelet-derived growth factor (PDGF) is involved in those refractory diseases. Imatinib mesylate inhibits th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kameda, Hideto, Suzuki, Miyuki, Takeuchi, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155225/
https://www.ncbi.nlm.nih.gov/pubmed/21901078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155225/
https://www.ncbi.nlm.nih.gov/pubmed/21901078

Ejemplares similares